Table 2.
Association between laboratory Parameters and Outcome (Death) in Severe COVID-19 cases.
| All Parameters Mean ± std.dev |
Outcome |
p value | |
|---|---|---|---|
| Survived (n = 6) | Died (n = 14) | ||
| Group | 1.0001 | ||
| S | 6 (100.0%) | 14 (100.0%) | |
| A | 0 (0.0%) | 0 (0.0%) | |
| H | 0 (0.0%) | 0 (0.0%) | |
| Age (Years) | 49.67 ± 22.42 | 62.08 ± 17.12 | 0.3982 |
| Gender | 0.1573 | ||
| Male | 1 (16.7%) | 8 (57.1%) | |
| Female | 5 (83.3%) | 6 (42.9%) | |
| Socio-Economic Status | 0.2723 | ||
| Good | 2 (33.3%) | 1 (7.1%) | |
| Medium | 4 (66.7%) | 11 (78.6%) | |
| Poor | 0 (0.0%) | 2 (14.3%) | |
| D-Dimer (ng/ml) | 2158.17 ± 1739.71 | 2685.36 ± 1769.03 | 0.4802 |
| S. Ferritin | 359.83 ± 262.29 | 425.52 ± 353.87 | 0.9672 |
| TAG | 219.50 ± 98.23 | 205.07 ± 83.33 | 0.9342 |
| Haemoglobin (g/dL) | 9.97 ± 2.83 | 11.70 ± 1.66 | 0.2012 |
| Haematocrit (%) | 30.37 ± 7.92 | 36.40 ± 4.80 | 0.0762 |
| TLC (/cu.mm)∗∗∗ | 8735.00 ± 3889.63 | 17073.57 ± 7079.49 | 0.0062 |
| ANC (/cu.mm)∗∗∗ | 6735.67 ± 3831.65 | 14806.50 ± 6319.92 | 0.0032 |
| Lymphocytes (/cu.mm) | 1783.00 ± 678.63 | 1989.43 ± 1785.99 | 0.6802 |
| Monocytes (/cu.mm) | 216.33 ± 271.33 | 277.64 ± 205.59 | 0.3222 |
| Platelet Count (Lac/cu.mm) | 3.06 ± 2.85 | 1.75 ± 0.88 | 0.2742 |
| Quantiferon TB Gold | 0.86 ± 1.48 | 0.02 ± 0.02 | 0.0712 |
| Quantiferon TB Gold +ve (>0.35 iu/ml) (Positive)∗∗∗ | 3 (50.0%) | 0 (0.0%) | 0.0183 |
| Mitogen∗∗∗ | 3.56 ± 4.49 | 0.37 ± 0.43 | 0.0232 |
| TO Antigen | 0.5493 | ||
| <50 | 4 (66.7%) | 12 (85.7%) | |
| 50–100 | 2 (33.3%) | 2 (14.3%) | |
| TH Antigen | 0.4323 | ||
| <50 | 3 (50.0%) | 11 (78.6%) | |
| 50–100 | 1 (16.7%) | 1 (7.1%) | |
| >100 | 2 (33.3%) | 2 (14.3%) | |
| AH Antigen | 0.5213 | ||
| <50 | 6 (100.0%) | 11 (78.6%) | |
| 50–100 | 0 (0.0%) | 3 (21.4%) | |
| Influenza Vaccine (Present) | 0 (0.0%) | 0 (0.0%) | 1.0001 |
| BCG Scar (Present) | 4 (66.7%) | 12 (85.7%) | 0.5493 |
| Diabetes (Present) | 2 (33.3%) | 1 (7.1%) | 0.2023 |
| ACE Inhibitor Use (Present) | 2 (33.3%) | 2 (14.3%) | 0.5493 |
| Steroid, HCQS, Convalescent plasma Use (Present) | 0 (0.0%) | 0 (0.0%) | 1.0001 |
| Religious Practices (Present) | 5 (83.3%) | 14 (100.0%) | 0.3003 |
∗∗∗Significant at p < 0.05, 1: Chi-Squared Test, 2: Wilcoxon-Mann-Whitney U Test, 3: Fisher's Exact Test.